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SUMMARY The spectrum of disease caused by parvovirus B19 infection 
ranges from asymptomatic to a serious disease. Parvovirus B19 plays 
a role in the pathomechanism of gloves and socks syndrome, erythema 
infectiosum, acute polyarthralgia, aplastic crisis in persons with hemolytic 
anemia, and birth defects. Gloves and socks syndrome has an acute 
febrile course. Painful edema of hands and feet, and numerous small 
confluent petechiae in the same localization are the most characteristic 
signs. Blisters and erosions may occur in oral mucosa. General 
discomfort and arthralgia accompany skin lesions. The disease tends 
to be self-limiting. A typical case of gloves and socks syndrome in a 36-
year-old woman is reported. Serological tests disclosed the parvovirus 
B19 infection, confirming the causal relationship between the syndrome 
and this infection.  
KEY WORDS: gloves and socks syndrome; parvovirus B19
INTRODUCTION 
 Gloves and socks syndrome shows cutane-
ous and mucosal symptoms, most often associ-
ated with parvovirus B19 infection. It was first de-
scribed by Harms et al. as papular-purpuric gloves 
and socks syndrome (1). The relation of clinical 
symptoms to parvovirus B19 infection was dem-
onstrated by Bagot et al. (2). The disease has 
an acute course and is accompanied by fever. It 
begins suddenly, with painful edema of the hands 
and feet that are covered by numerous small con-
fluent petechiae in a few days. Lesions may cover 
the buttocks, elbows and knees as well. Blisters 
and erosions may occur in oral mucosa. Elevated 
body temperature, general discomfort and arthral-
gia accompany skin lesions. The disease tends to 
be self-limiting. The symptoms, dermal, mucosal 
or general, subside in 7-14 days.
 Parvovirus B19 is also of importance in the 
pathomechanism of other diseases such as ery-
thema infectiosum (3), acute polyarthralgia (4), 
and aplastic crisis in persons with hemolytic ane-
mia (5,6). In women, this infection may cause birth 
defects (7). 
CASE REPORT
 In a 36-year-old female patient, the illness be-
gan with itching of the hands and feet, followed by 
edema and redness in several hours. The patient 
had sore throat and myalgia. Dermal symptoms 
were expanding gradually in the form of small 
blue-purple papules on the hands and feet. On 
day 2 of the disease, her body temperature rose 
to 39.5 ºC. At that time the patient was on anti-
histaminic (clemastine, cetirizine) and anti-inflam-
matory medication (metamizole), along with cal-
cium, yet with no effect. On day 3, the patient pre-
sented to the hospital. On admission, she showed 
the following symptoms: edema intensifying the 
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blue-purple reddening of the hands and feet (Figs. 
1 and 2), and similar yet less pronounced symp-
toms on the elbows, buttocks and in armpits. Red-
ness and small papules were discernible around 
her lips. The throat was reddened. Elevated body 
temperature persisted for 3 days, 2 of these at hos-
pital, then returned to normal. There was gradual 
regression of dermal symptoms. On day 15, mild 
redness and desquamation were observed on the 
hands and feet. Pain in the elbow and knee joints 
persisted for 2 months. 
 Additional tests showed normal erythrocyte, 
leukocyte and platelet counts, and erythrocyte 
sedimentation rate (32 mm/h). On day 4, erythro-
cytes and 25 mg/dL protein were found in urine. 
Urinary changes subsided after several days. 
The results of biochemical blood tests (glucose, 
urea, bilirubin, creatinine, GOT, GPT levels and 
electrolytes) were close to normal. In addition, 
an average level of C3c and C4 components of 
complement, negative result for rheumatoid factor, 
and low level of ASL were recorded. At the same 
time, the level of CRPm increased to 63.30 mg/L. 
Serologic tests for B19 parvovirus infection were 
performed on three occasions, i.e. on days 4, 21 
and 52. The result of IgG and IgM was negative 
on day 4 but positive on days 21 and 52. These 
tests were performed by ELISA method. On day 
4 absorption within IgG was 0398, ratio 0.47; ab-
sorption within IgM was 0573, ratio 1.35; on day 
21 absorption within IgG was 2345, ratio 2.77; ab-
sorption within IgM was 2659, ratio 6.29; and on 
day 52 absorption within IgG was 2201, ratio 2.60; 
absorption within IgM 0862, ratio 2.04.
 Samples for histopathologic tests were ob-
tained from the infected areas on the feet: cu-
ticular hyperkeratosis, significant stromal edema 
in the dermis, and small inflammatory infiltrates 
around blood vessels were recorded. There was 
no extravasation of erythrocytes. Direct immuno-
fluorescence testing showed no accumulation of 
IgG, IgM or IgA class antibodies, or of the compo-
nents of complement. 
 During hospital stay, the patient was treated 
with clemastine, calcium and paracetamol, as 
necessary. 
DISCUSSION
 Harms et al. (1) were the first to describe the 
syndrome now known as petechial gloves and 
socks syndrome. They described 5 patients aged 
16-31 with limited petechial symptoms on the 
hands and feet. In 3 patients the symptoms ap-
peared on the cheeks, the inside of thighs, but-
tocks and penis. All patients showed changes of 
oral mucosa, accompanied by elevated body tem-
perature. The course of the disease was acute, 
and the symptoms persisted for 7-14 days. Leu-
kopenia was observed in some cases. Bagot et 
al. (2) described a similar case in a woman. They 
found the characteristic symptoms of the disease 
to be associated with parvovirus B19 infection, 
which was demonstrated by detection of specific 
antibodies of IgM class. Other authors also ob-
served the association between the syndrome de-
scribed by Harms et al. and parvovirus infection 
(8-11) as well as with simultaneous herpesvirus 7 
Figure 1. Erythematopapular eruption on the 
palms.
Figure 2. Erythematopapular eruption on the 
feet.
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infection and B19 parvovirus infection (12). Typi-
cal symptoms of the gloves and socks syndrome 
have also been described as a drug reaction after 
trimethoprim/sulfamethoxazole (13).
 B19 parvovirus is an unenveloped virus, 20-25 
nm in diameter. The infection shows a droplet pat-
tern and may be asymptomatic. Typically, viremia 
occurs one week after the infection, lasting for a 
few days and with general symptoms (fever, dis-
comfort, myalgia), and possible skin symptoms. 
Viremia is followed by a specific response, initially 
of the IgM class, and then, in several days, of the 
IgG class. Ten days after inoculation there are no 
erythroid precursors in the bone marrow and a 
small decrease in hemoglobin level in peripheral 
blood is observed (14). 
 However, the B19 parvovirus infection may have 
a clinical course different from that in the gloves 
and socks syndrome. In children, parvovirus B19 
causes erythema infectiosum. The disease is ob-
served in children aged 4-11. The symptoms in-
clude intensive erythema on the cheeks and trunk, 
and reticular erythema on the limbs. Skin symp-
toms remain for 1-2 days, and recede without trac-
es. Another manifestation of B19 parvovirus infec-
tion is acute polyarthralgia and arthritis. Adults are 
most often affected by the disease that involves 
symmetrically small joints of the hands and wrists, 
rarely elbows and knees. The symptoms subside 
after 2 weeks, although may sometimes persist 
for several months. Parvovirus B19 can also play 
a role in the pathomechanism of aplastic crisis in 
individuals with chronic hemolytic anemia, e.g., in 
persons with sickle cell anemia, as it leads to dam-
age to erythroid precursors in the bone marrow. 
A chronic parvovirus infection in immunocompro-
mised individuals may lead to long-lasting or re-
current anemia. A case of chronic skin symptoms 
and anemia as the result of parvovirus B19 infec-
tion in a HIV positive patient has been reported 
(15). Parvovirus B19 infection in pregnant women 
can cause birth defects, usually hydrocephalus, or 
even lead to spontaneous abortion.
 The diversity of symptoms associated with the 
infection is related to the pathomechanism of par-
vovirus B19 infection. Through the receptor, anti-
gen P on erythrocytes, the virus affects vascular 
endothelial cells and fetal myocytes (16). 
 The group of symptoms in the course of pete-
chial gloves and socks syndrome should be dif-
ferentiated from drug reactions (chemotherapy: 
doxorubicyn, cytarabin; erythrocyte and platelet 
transfusion; antibiotic therapy) (17), skin symp-
toms in serum sickness (18), Gianotti-Crosti syn-
drome (19), measles (20), and Kawasaki disease 
(21).
 In our patient, a typical acute course of the dis-
ease symptoms was observed. Skin lesions, i.e. 
edema and erythema, had a characteristic acral 
localization. Less pronounced erythema and pap-
ules appeared on the buttocks, elbows and in 
armpits. In oral mucosa, only redness of the throat 
was observed. In the preliminary stage of the dis-
ease, body temperature was 39.0 ºC and contin-
ued so for 3 days only. The patient felt discomfort 
and muscle pain during the period of symptom in-
tensification. Skin lesions were withdrawing with 
desquamation and gradual decrease of erythema 
and edema severity.
 During convalescence, there was no discol-
oration connected with the presence of hemo-
siderin.  Histopathologic examination showed no 
extravasation of erythrocytes. Perhaps the gloves 
and socks syndrome may proceed without pete-
chiae, depending on the severity of vascular wall 
changes. However, a case of severe vascular wall 
lesions that led to skin necrosis is described in the 
literature (9). 
 The parvovirus B19 infection in our patient was 
proved by serologic tests. The case described 
supports the substantial association between the 
gloves and socks syndrome and parvovirus B19 
infection.  
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For winter sports, Nivea cream; year 1934.
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